Tenet Healthcare Corporation (NYSE: THC) is a prominent player in the healthcare sector, providing a wide range of services through its network of hospitals and outpatient centers. The company competes with other healthcare giants like HCA Healthcare and Community Health Systems. On February 12, 2026, RBC Capital set a new price target of $277 for THC, indicating a potential 22.38% increase from its current trading price of $226.35.
Recently, Tenet Healthcare's stock experienced a notable increase of 11.8% during mid-day trading, reaching a high of $216.04. This surge followed the release of a stronger-than-expected earnings report, which saw the stock last traded at $215.90. Despite a 4% decline in trading volume, the stock's performance was impressive, with 897,753 shares changing hands compared to the average session volume of 933,138 shares.
The company's earnings report revealed an EPS of $4.70 for the quarter, surpassing analysts' consensus estimates of $4.05 by $0.65. Tenet Healthcare achieved a net margin of 6.49% and a return on equity of 25.11%. Additionally, the business's revenue increased by 8.9% compared to the same quarter last year, showcasing its strong financial performance.
Currently, THC is priced at $226.35, reflecting a significant increase of 17.26% or $33.31. The stock has fluctuated between a low of $186.50 and a high of $229 today, with $229 marking its highest price over the past year. The lowest price for THC in the past year was $109.82. The company has a market capitalization of approximately $19.89 billion, with today's trading volume at 3,158,135 shares.
